Chronic Diseases 2020
Deputy Head of the Department Istanbul University, Turkey, E-mail: [email protected]
Chronic Diseases grows as a long lasting and often incurable diseases. This creates the increasing thirst in the market to enquire about them. This 4th International Conference on Chronic Diseases will offer an extradentary platform to discuss about it. By utilizing this opportunity, the Chronic Diseases 2020 will offer a better comprehension of predicting, analysing and delivering the potential cure for Chronic Diseases.
There is wide market for chronic diseases management globally owing to its application in various field such as asthma, cancer, cardiovascular, diabetes, stroke and many more. Increasing prevalence of chronic disease globally considering the major factor which lead the growth of chronic diseases management market globally. According to a Cancer research U.K, in 2014, around 356,860 people were diagnosed with cancer. Report suggest that it incident of cancer are rising rapidly in last few years and expected to grow quickly in the coming future owing to unhealthy diets, high rate of smoke and alcohol consumption.
The global Health market was about $10.5 billion in 2014, estimated to register a high CAGR of 33.5% during till 2020.
Global Anti-diabetics Market size is projected to reach USD 116.1 billion by 2023; as per the latest research report by Global Market Insights, Inc. As pre the estimation there will be 10.9% CAGR increase in Global insulin antidiabetics market size which was evaluated to be USD 51.1 billion in 2015.Global anti-obesity therapeutics market is estimated to hike at a CAGR of above 20.0%. The global obesity surgery device market is estimated at USD 1,432.4 million in 2014. It is likely to grow at a CAGR of 9.6% from 2014 to 2020 to reach USD 2,489.5 million in 2020.
The global chronic obstructive pulmonary disease (COPD) drugs market is estimated to grow at a CAGR of 4.85% during the period 2016-2020.
Europe Autoimmune disease therapeutics market is projected to create up to USD 4.58 billion at a CAGR of 1.6% by 2020 control and prevent diseases. However, the global autoimmune diseases treatment market is estimated to reach $15.97 billion by 2022 at CAGR of 3.80%.
Cardiovascular Diseases Therapeutics is estimated to increase at a CAGR of 4.1% globally. The top eight markets to grow are of Germany, France, Italy, Spain, Japan, UK and USA.
With the help of the all above given statistics we can make sure that chronic diseases are one among the major threats for which the continues effort must be taken to discuss about it.